The NIH rejected a petition urging the agency to widen access to a cancer drug b...
89bio said its experimental treatment improved liver scarring at more than three...
A new bill that would ban government use of quality-adjusted life years is misgu...
Health disparities are not just the stuff of dry statistics and academic studies...
A potential class action lawsuit against Cerebral raises questions about whether...
Stanford cardiologist Euan Ashley and his research team received a Guinness Worl...
This change is profoundly unsettling to living kidney donors around the country.
Africa is grappling with not one, but two outbreaks of Marburg fever, a disease ...
A study finds that the slightly elevated risk of breast cancer doesn't change wi...
A combination of economic turbulence and rapid technological advances means inve...
Africa remains a largely untapped market for clinical trials, with data showing ...
BioNTech and OncoC4 will co-develop OncoC4’s ONC-392 as a monotherapy or combina...
Predictive Oncology’s PEDAL platform enables more informed selection of drug-tum...
The strategic efforts from two companies have raised the profile of NASH, an ind...
The partnership will focus on developing mRNA vaccines to treat certain autoimmu...
Pharmaceutical Technology analyses recent regulatory and trial announcements tha...